- Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy. Wheeler, H.E., Gamazon, E.R., Wing, C., Njiaju, U.O., Njoku, C., Baldwin, R.M., Owzar, K., Jiang, C., Watson, D., Shterev, I., Kubo, M., Zembutsu, H., Winer, E.P., Hudis, C.A., Shulman, L.N., Nakamura, Y., Ratain, M.J., Kroetz, D.L., Cox, N.J., Dolan, M.E. Clin. Cancer Res. (2013)